General Science Board Members

All advisory board members will assist with the annual stakeholder meeting; website outreach to professionals and patients; assist CCF to acquire CME funding to educate the general medical community; provide administrative guidance, assistance and strategic direction; other responsibilities to be determined.

Steven Alberts, MD

Dr. Steven Alberts is a professor of Oncology in the Mayo Clinic College of Medicine and a consultant in the Division of Medical Oncology. In addition, he is the medical director for the Clinical Research Office and the coordinator for Upper GI Malignancies, North Central Cancer Treatment Group. He also serves as the chair for the GI Cancer Disease-Oriented Group for the Cancer Center. Dr. Alberts’s research interests are focused in gastrointestinal malignancies, epidemiology, cancer prevention, and cancer in American Indians and Alaska Natives. Dr. Alberts has developed an international reputation for his working in the treatment of upper gastrointestinal malignancies. He conducts a variety of clinical trials for this group of diseases. He has a variety of publications outlining this research and is...

Oliver Bathe, MD, FRCS(C)

Dr. Bathe is a surgical oncologist with a special interest in hepatobiliary, pancreatic and gastrointestinal tumors. His clinical research interests relate to the patient population he treats, with a goal of improving outcomes. As a result of his clinical trial involvement, he is a member of the NCIC Clinical Trials Group Gastrointestinal Tumor Group Executive, co-chair of the NCIC Hepatobiliary Working Group, and member of the Intergroup Hepatobiliary Task Force. He also has a basic and translational research program. His lab is focused on understanding the host response against tumor. He directs the University of Calgary Hepatobiliary and Gastrointestinal Tumor Bank which currently houses over 10,000 samples. His tumor banking efforts have attracted a number of national and international collaborations, including with The Cancer Genome...

William C. Chapman, MD, FACS

Dr. Chapman grew up in North Carolina where he attended the University of North Carolina graduating in 1980, and subsequently graduating from the Medical University of South Carolina in 1984. He received his surgical training at Vanderbilt University in Nashville, including a two-year postdoctoral fellowship and completing his Chief Resident Year in 1991. He then completed a fellowship in Hepatobiliary Surgery and Liver Transplantation at King’s College Hospital in London, England before returning to the faculty at the Vanderbilt Medical Center in the Division of Hepatobiliary Surgery and Liver Transplantation. In 2002, he was recruited to Washington University as Professor and Chief of the Section of Abdominal Transplantation, and in 2007 he was asked to assume the directorship of the Division of General Surgery...

Michael Choti, MD, MBA

Michael Choti, M.D., M.B.A. is the Hall and Mary Lucile Shannon Distinguished Chair in Surgery and Chair of the Department of Surgery at UT Southwestern Medical Center in Dallas, TX. Dr. Choti received his MD degree at Yale University, general surgery training at the University of Pennsylvania, and completed the surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center before joining the division of Surgical Oncology at Johns Hopkins.  He moved to  UT Southwestern in 2013. Dr. Choti has served on various leadership positions in national and international societies and has chaired study sections for the American Cancer Society. He served as Chair of the NCI-CTEP Hepatobiliary Task Force as well as on the American College of Surgeons’ Commission on Cancer, the GI committees of...

Laura Dawson, MD

Dr. Dawson is a Full Professor / practicing radiation oncologist in the Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto. She is an internationally recognized leader in hepatobiliary radiation therapy, and is principal investigator of many clinical trials of radiation therapy for hepatocellular carcinoma. She has published over 100 scientific papers mostly related to liver cancer radiation therapy, related to hepatic malignancies. She has been a speaker at many international oncology meetings, and she has received numerous grants and honors related to her research in radiation therapy for liver...

Yuman Fong, MD

Yuman Fong, M.D., an internationally recognized expert in hepatobiliary cancer and in the use of genetically modified viruses to combat malignant disease, has been named chair of the Department of Surgery at City of Hope. Dr. Fong comes to City of Hope from Memorial Sloan Kettering Cancer Center in New York, where he held for the last 14 years the Murray F. Brennan Chair in Surgery and Professorship in surgery at Cornell Medical College. A specialist in cancers of the liver, bile duct, gallbladder and pancreas, Dr. Fong has pioneered many surgical, laparoscopic, robotic and ablative therapies for these cancers, which are diagnosed in more than a million people worldwide each year. Nationally and internationally, he has been involved in studies aimed at understanding,...

T. Clark Gamblin, MD, MS

Dr. T. Clark Gamblin is a native of Jackson, Mississippi. Dr. Gamblin obtained his BS from Mississippi State University and graduated from the University of Mississippi School of Medicine in 1998. Dr. Gamblin then completed his general surgery residency at Mercer University followed by a surgical oncology fellowship at the University of Pittsburgh. After fellowship he joined the University of Pittsburgh faculty in the Divisions of Transplantation and Surgical Oncology. Shortly after joining the faculty, Dr. Gamblin obtained a Master of Science in clinical research from the University of Pittsburgh. He also obtained NIH funding examining the role of liver cancer stem cells and served as a primary investigator on multiple liver clinical trials focused on hepatocellular carcinoma. Dr. Gamblin is currently the Chief...

Laura Goff, MD

Dr. Goff is a medical oncologist who specializes in gastrointestinal cancers with an emphasis on tumors of the liver and biliary tract. Dr. Goff received her medical degree from the University of Texas Health Science Center in San Antonio. She went on to complete a residency in Internal Medicine at the University of Texas Southwestern Medical Center at Dallas and then moved to Vanderbilt University for fellowship training in Hematology and Oncology. She joined the faculty in the GI Oncology program at Vanderbilt in 2007. Dr. Goff is interested in developing the use of new therapeutics in gastrointestinal malignancies through clinical trials and translational...

Gregory Gores, MD

Gregory J. Gores, M.D., is executive dean for research at Mayo Clinic and is responsible for leading and managing all of Mayo’s research activities. He also serves as chair of the Division of Gastroenterology and Hepatology and holds the academic rank of professor of physiology and medicine. He is recognized with the distinction of a named professorship, the Reuben R. Eisenberg Professorship. A native of North Dakota, Dr. Gores received his undergraduate (Phi Beta Kappa) and M.D. (Alpha Omega Alpha) degrees from the University of North Dakota. He completed a fellowship in internal medicine and gastroenterology at Mayo Clinic Graduate School of Medicine. During his gastroenterology fellowship, he was a National Institutes of Health (NIH) fellow in the laboratory of Nicholas F. LaRusso, M.D....

Daniel G. Haller, MD, FACP, FRCP

Dr. Haller joined the faculty of the University of Pennsylvania in 1980. His chief areas of clinical research are in the management of gastrointestinal malignancies. He was awarded the Deenie Greitzer Gastrointestinal Medical Oncology Professorship in 2009. He has been awarded the John Glick Teaching Award and the Clinical Specialist Award of the Year from Penn. Dr. Haller received his M.D. from the University of Pittsburgh. He completed residency and oncology training at Georgetown University. He then was Head of the Medicine Section of the Clinical Investigations Branch of the National Cancer Institute. Dr. Haller also served as the Gastrointestinal Committee Chair for ECOG, and is currently the co-chair emeritus of the US NCI GI Intergroup. He is a Fellow of ASCO, and has...

Tomoaki Kato, MD

Dr. Tomoaki Kato, Professor of Surgery, NewYork-Presbyterian Hospital/Columbia University Medical Center Chief of the Division of Abdominal Organ Transplantation, is a renowned expert in liver and intestinal transplantation and complex abdominal and Hepatobiliary surgeries. Dr. Kato leads the new program for small bowel and multivisceral transplantation. These rarely performed procedures are reserved for patients with complex abdominal pathologies – primarily short gut syndrome and intestinal dysmotility in children, and mesenteric thrombosis and trauma in adults and ex vivo resection, operating on an organ removed from the patient’s body and then returning it to the patient. Since joining NewYork-Presbyterian Hospital/Columbia in August 2008, Dr Kato has been leading the institution’s liver transplant program, using both deceased and living donor livers. The center has generated some...

Richard Kim, MD

Dr. Richard Kim is an medical oncologist in the Gastrointestinal Oncology Department at Moffitt Cancer Center. He is an assistant professor of oncology at the University of South Florida College of Medicine. Dr. Kim received his medical degree from the University of Miami School of Medicine and completed a residency in internal medicine at the University of Illinois at Chicago. He pursued a post-doctoral fellowship in hematology and medical oncology at Yale University Comprehensive Cancer Center in New Haven, CT. Dr. Kim’s clinical and research interests focus on gastrointestinal tumors, in particular hepatobiliary and colon cancer. He is a principal investigator in multiple investigator-initiated I and II trials using novel targeted agents including several cholangiocarcinoma trials. Dr. Kim was named 2008 Teacher of the...

Robin D. Kim, MD

Dr. Kim received his Bachelor of Arts from The Johns Hopkins University and his Doctor of Medicine from Jefferson Medical College. He completed his residency in General Surgery at the University of Massachusetts School of Medicine which included a two-year research fellowship in liver regeneration and cancer. Following his residency, Dr. Kim went on to the University of Toronto and the Hospital for Sick Children for his Fellowship in adult and pediatric Multi-organ Transplantation and Hepatobiliary Surgery. Here, he gained expertise in the surgical management of liver, biliary and pancreatic diseases. This training balanced both a transplantation and oncologic approach. Dr. Kim spent 5 years as faculty at the University of Florida, where he developed a robust practice specializing in surgery for diseases of...

Jennifer Knox, MD, MSc, FRCPC

Dr. Jennifer Knox is an Associate Professor of Medicine at the University of Toronto and a staff member of the Department of Medical Oncology of Princess Margaret Cancer Centre. Her research interests include developing new cancer treatments, and the multidisciplinary management of gastrointestinal cancers, with special focus on hepatobiliary and pancreas cancers. She has been P.I. of a number of clinical trials conducted with the National Cancer Institute of Canada (NCIC) as well as the NCI-US, now with over 200 publications. In 2010, she was awarded the University of Toronto Young Investigator Award for her body of work to date. Currently she chairs the NCIC Hepatobiliary and Kidney cancer working groups as well as co-chairs the NCI-intergroup task force for trials in hepatobiliary cancers. She leads the Gastrointestinal (GI) Multidisciplinary Site group at The...

Heinz-Josef Lenz, MD, FAC

Dr. Lenz, is the Associate Director for Clinical Research and Co-Leader of the Gastrointestinal Cancers Program at the USC Norris Comprehensive Cancer Center. Dr. Lenz is Professor of Medicine and Preventive Medicine, Section Head of GI Oncology in the Division of Medical Oncology and Co-Director of the Colorectal Center at the Keck School of Medicine of the University of Southern California. Dr. Lenz received his medical degree from Johannes-Gutenberg Universität in Mainz, Germany, in 1985. He completed a residency in Hematology and Oncology at the University Hospital Tübingen in Germany, a clerkship in Oncology at George Washington University in Washington, DC, and a clerkship in Hematology at Beth Israel Hospital of Harvard Medical School in Boston, Massachusetts. He served subsequent fellowships in Biochemistry and...

Robert C. G. Martin II, MD, PhD

Robert C. G. Martin, II, M.D. PhD, is The Sam and Lolita Weakley Endowed Chair in Surgical Oncology, The Director of the Division of Surgical Oncology, faculty member of the James Graham Brown Cancer Center, and a Professor in the Department of Surgery. He was appointed to the University of Louisville in 2002 as an Assistant Professor and achieved Professor of Surgery in 2011. Dr. Martin received his M.D. from the University of Louisville School of Medicine and his surgical oncology training and hepato-pancreatico-biliary training from Memorial Sloan-Kettering Cancer Center, and his PhD from the Department of Pharmacology and Toxiciology at the University of Louisville School of Medicine. Dr Martin has mentored over 30 medical students and masters’ students through both the summer research...

Rebecca A. Miksad, MD, MPH

Dr. Miksad received a B.A in economics from Harvard, an MD with honors in research from Cornell University, and an MPH from Harvard. She completed her internal medicine residency at New York-Presbyterian Hospital and her Hematology/Oncology fellowship at BIDMC. She completed the NCI-funded post-doctoral fellowship in the Dana-Farber/Harvard Cancer Center Program in Cancer Outcomes Research Training (PCORT). Dr. Miksad’s research goal is to improve treatments and outcomes for patients with Hepatobiliary and Pancreatic Cancer. She is engaged in translational clinical trial and health services/outcomes research as an Attending Physician in medical oncology at Beth Israel Deaconess Medical Center and as Senior Scientist at the Institute for Technology Assessment at Massachusetts General Hospital. Dr. Miksad’s research is currently supported by a K23 from the National...

Bruce D. Minsky, MD

Bruce D. Minsky, MD, is Professor and Deputy Head of the Division of Radiation Oncology at the MD Anderson Cancer Center. He is also the Director of Clinical Research for the Department of Radiation Oncology and an active clinician and clinical research investigator on the Gastrointestinal Cancer multi-disciplinary team. He holds the Frank T. McGraw Memorial Chair for the Study of Cancer. He received his medical degree from the University of Massachusetts in 1982. He was a Medical Intern at New England Deaconess Hospital and completed his residency in radiation therapy at the Harvard Joint Center for Radiation Therapy. Following completion of his residency in 1986 he spent the first 20 years of his career at Memorial Sloan Kettering Cancer Center as a clinician...

Tushar Patel, MB, ChB

Tushar Patel is Professor of Medicine at the Mayo Clinic College of Medicine and a member of the Departments of Transplantation and Cancer Biology at Mayo Clinic Florida. He is a graduate of the University of Glasgow in Scotland, and completed clinical training with specialized training as a clinician-investigator at the Mayo Clinic. His clinical practice in focused on liver transplantation and the multidisciplinary treatment of liver cancers. His laboratory-based research program is focused on basic and translational research in liver cancers, and in particular the molecular mechanisms of cancer formation in the bile ducts. Current research is on identifying basic genetic mechanisms and novel target molecules that could be useful to treat these cancers. Many of the more than 100 original scientific papers...

Timothy Pawlik, MD, MPH, PhD

Dr. Pawlik received his undergraduate degree from Georgetown University and his medical degree from Tufts University School of Medicine. Dr. Pawlik completed surgical training at the University of Michigan Hospital and spent two years at the Massachusetts General Hospital as a surgical oncology research fellow. He then went on for advanced training in surgical oncology at The University of Texas M. D. Anderson Cancer Center in Houston. Dr. Pawlik’s main clinical interests include alimentary tract surgery, with a special interest in hepatic, pancreatic and biliary diseases. Dr. Pawlik also has an interest in medical ethics and completed a fellowship in medical ethics at the Harvard School of Public Health as well as a Masters in Theology from Harvard Divinity School in Boston. In addition,...

Myron E. Schwartz, MD

Dr. Schwartz graduated from Jefferson Medical College AOA in 1976. After a year of rotating internship he joined the National Health Service Corps for three years as a general practitioner in rural Virginia. Dr. Schwartz came to Mount Sinai in 1981, completed residencies in general and vascular surgery, and joined the faculty in 1987. He worked with Charles Miller, MD to establish the Mount Sinai Liver Transplant Program in 1988, and since then has devoted his career to hepatobiliary surgery and transplantation. Over the years he has served as Director of Pediatric and Adult Liver Transplantation, and more recently has focused on liver cancer. Dr. Schwartz is currently the Clinical Director of the Mount Sinai Liver Cancer Program. Together with Research Director Josep Llovet...

Robert R. Selby, M.D.

Dr. Rick Selby is Professor of Surgery and chief of the Division of Hepato-Biliary-Pancreatic Surgery and Abdominal Organ Transplantation at Keck USC School of Medicine in Los Angeles. The division provides HPB operative and management services at LA County Hospital, USC University Hospital, Huntington Hospital in Pasadena, Hoag Hospital in Newport Beach as well as St. Vincent’s and Good Samaritan Hospitals in downtown LA. The divisional faculty is active in the treatment planning and management of patients w liver, pancreatic and biliary malignancies through multidisciplinary tumor boards while supporting academic efforts through a vibrant tissue and fluid repository and relational data-basing for many of the malignancies in these patient cohorts. An active clinical research program completes the picture and allows possible stratification of patients...

Weijing Sun, MD

Dr. Sun is professor of medicine, Director of GI Cancer of Hematology-Oncology Division, Co-Director of UPMC Gastrointestinal Cancer Center of Excellence, University of Pittsburgh Cancer Institute. He is focusing on the treatment and clinical research of GI malignances, mainly on the development of new drugs and biologic/targeted oriented agents in treatment/therapy (including translational research) of Gastrointestinal Malignances with great experiences in the early phase clinical trial (phase I, II) designing, protocol development and conduction, and many of these have been published. He has authored many publications including original clinical research articles, reviews, and invited editorial commends in a variety of peer-reviewed journals. He has also written chapters as a GI oncology expert for several medical textbooks including WebMD, Textbook of Gastroenterology. Has had more than 70 publications....

Jeffrey C. Weinreb, MD, FACR, FISMRM

Dr. Weinreb is Professor of Diagnostic Radiology at the Yale School of Medicine and Chief of MRI and Director of Medical Imaging at Yale-New Haven Hospital. He is a leading authority on MRI contrast agents and the use of MRI (magnetic resonance imaging) for the body, focusing on the liver. As Chairman of the American College of Radiology Commission on Quality and Safety, Dr. Weinreb spearheaded efforts to improve the quality of medical imaging in the USA. Dr. Weinreb has served as President of the SCBT/MR, President of the New York Roentgen Society, and Vice President of the ACR, and he currently chairs the annual ACR Forum.He has authored/co-authored more than 150 peer-reviewed manuscripts, 12 book chapters and 3 textbooks on MRI, served on...